Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Hodgkin lymphomas that are indolent have been linked to psychological distress.

2.

De-escalation Misses the Mark in Inflammatory Breast Cancer

3.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

4.

Hereditary cancer has a rare and underreported cause.

5.

Morning Immunotherapy Does Not Boost Lung Cancer Survival


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot